New & Noteworthy

Submit New & Noteworthy

May 2018

Erythromycin Tablets

Amneal Pharmaceuticals

Amneal Pharmaceuticals has received FDA approval for erythromycin tablets USP, in 250 mg and 500 mg strengths. The product is a therapeutic equivalent for the reference listed drug (RLD) erythromycin tablets from Arbor Pharmaceuticals and is an immediate release oral tablet. They are packaged in 100-count bottles and are now available to wholesalers, distributors, and direct.

Click here to view product detail on Findit.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

Just answer the following quick question for your chance to win:

To continue, you must either login or register: